Stanza Shows Lasting Benefits for Fibromyalgia Symptoms in 12-Month Extension Study

Swing Therapeutics announced new data on the long-term durability of Stanza, a digital behavioral therapy for the treatment of fibromyalgia symptoms, at the 2025 Society of Behavioral Medicine annual meeting this week. The study, an extension of the REACT-FM trial, followed participants for 12 months to assess the durability of benefits achieved through Stanza, an … Read more » The post Stanza Shows Lasting Benefits for Fibromyalgia Symptoms in 12-Month Extension Study appeared first on Swing Therapeutics .